SCHEMBL9747922

SCHEMBL9747922

CC1CCC(=O)NC1C(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDUA P35475 1/20 0.34
CAD P27708 1/20 0.33
SLC1A2 P43004 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ITGB3 P05106 1/20 0.31
ITGB2 P05107 1/20 0.31
ITGB1 P05556 1/20 0.31
ITGAV P06756 1/20 0.31
ITGA2B P08514 1/20 0.31
ITGA5 P08648 1/20 0.31
ITGB5 P18084 1/20 0.31
ITGAL P20701 1/20 0.31
BLM P54132 1/20 0.31
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7330767 0.79 ITGB1 (0.42) IDUACADITGB3ITGB2ITGB1
SCHEMBL31694886 0.79 ITGB1 (0.42) IDUACADITGB3ITGB2ITGB1
SCHEMBL31697657 0.79 ITGB1 (0.42) IDUACADITGB3ITGB2ITGB1
SCHEMBL7282443 0.79 ITGB1 (0.42) IDUACADITGB3ITGB2ITGB1
SCHEMBL19850672 0.79 ITGB1 (0.42) IDUACADITGB3ITGB2ITGB1
SCHEMBL4629492 0.79 ITGB1 (0.42) IDUACADITGB3ITGB2ITGB1
SCHEMBL4629491 0.79 ITGB1 (0.42) IDUACADITGB3ITGB2ITGB1
SCHEMBL19557917 0.78 SLC1A2 (0.31) SLC1A2
SCHEMBL23002180 0.78 IDUA (0.39) IDUACADSLC1A2MEN1KMT2A
SCHEMBL7395743 0.78 SLC1A2 (0.47) IDUACADSLC1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210051963-A1 METHODS AND COMPOSITIONS TO IMPROVE PLANT HEALTH AND/OR PLANT PERFORMANCE Plant Response, Inc. 2021-02-25 US disclosed
US-5151497-A Central nervous system disorders, antidepressants, epilepsy and cognition activators JAPAN TOBACCO INC. (JP) 1992-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210051963-A1 METHODS AND COMPOSITIONS TO IMPROVE PLANT HEALTH AND/OR PLANT PERFORMANCE GET3, PAH, ITPA IDUA 892/4885CAD 4428/4885SLC1A2 889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.